Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Celecoxib WBA in healthy volunteers
NCT02602509Phase 1Completed
- Sponsor
- National University Hospital
- Start
- Nov 2015
- Primary completion
- Feb 2016
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of celecoxib in Tuberculosis (TB) (2 arms), sponsored by National University Hospital. Primary endpoint: Whole Blood Bactericidal Activity at 8 hours. Started Nov 2015; status: completed.
02
Drugs
celecoxib
03
Conditions
Tuberculosis (TB)
Beyond the preview
Go deeper on NCT02602509.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02602509.